Interestingly, NASH and most IMIDs share some molecular characteristics such the activation of the tumor pathways depending on tumor necrosis factor (TNF)-α or the imbalance in T-cell subtypes such as Th17/Treg. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.